Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
AAPS PharmSciTech ; 23(1): 22, 2021 Dec 14.
Artículo en Inglés | MEDLINE | ID: mdl-34907488

RESUMEN

The assessment of drug taste is crucial for pediatric treatments so that formulations can be developed to enhance their effectiveness. In this study, in vivo and in vitro methods were applied to evaluate the taste of tablets of three drugs administered to children without taste-masking excipients to treat tropical diseases, namely artesunate-mefloquine (ASMQ), praziquantel (PZQ), and benznidazole (BNZ). In the first method, a model of rat palatability was adapted with recirculation to ensure sample dispersion, and the data were analyzed using ANOVA (single factor, 95%). The taste assessment results (in vivo) indicated an aversion to the three medicines, denoted by the animals retracting themselves to the bottom of the box after the first contact with the drugs. For the placebo samples, the animals behaved normally, indicating that taste perception was acceptable. The second method was based on the in vitro analysis of capacitance data from a homemade impedimetric electronic tongue. Consistent with the in vivo taste assessment results, the data points obtained with PZQ, ASMQ, and BNZ were far away from those of their placebos in a map built with the multidimensional projection technique referred to as Interactive Document Mapping (IDMAP). A combined analysis of the results with the two methods allowed us to confirm the bitterness of the three drugs, also pointing to electronic tongues as a promising tool to replace in vivo palatability tests.


Asunto(s)
Mefloquina , Praziquantel , Animales , Artesunato , Niño , Humanos , Nitroimidazoles , Ratas , Comprimidos , Gusto
3.
Pharmaceutics ; 13(8)2021 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-34452075

RESUMEN

For the last 40 years, praziquantel has been the standard treatment for schistosomiasis, a neglected parasitic disease affecting more than 250 million people worldwide. However, there is no suitable paediatric formulation on the market, leading to off-label use and the splitting of commercial tablets for adults. In this study, we use a recently available technology, direct powder extrusion (DPE) three-dimensional printing (3DP), to prepare paediatric Printlets™ (3D printed tablets) of amorphous solid dispersions of praziquantel with Kollidon® VA 64 and surfactants (Span™ 20 or Kolliphor® SLS). Printlets were successfully printed from both pellets and powders obtained from extrudates by hot melt extrusion (HME). In vitro dissolution studies showed a greater than four-fold increase in praziquantel release, due to the formation of amorphous solid dispersions. In vitro palatability data indicated that the printlets were in the range of praziquantel tolerability, highlighting the taste masking capabilities of this technology without the need for additional taste masking excipients. This work has demonstrated the possibility of 3D printing tablets using pellets or powder forms obtained by HME, avoiding the use of filaments in fused deposition modelling 3DP. Moreover, the main formulation hurdles of praziquantel, such as low drug solubility, inadequate taste, and high and variable dose requirements, can be overcome using this technology.

4.
J Ethnopharmacol ; 241: 111970, 2019 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-31128150

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Jatropha curcas L. is a plant with high cultural significance for quilombola communities of Oriximiná (Pará State, Brazil). Although the plant is highly toxic, its seeds are used in these communities to treat tuberculosis and related diseases and symptoms. AIM OF THE STUDY: This study was designed to provide a scientific rationale for the traditional detoxification method and use of J. curcas seeds in quilombola communities of Oriximiná. MATERIALS AND METHODS: J. curcas seeds were manually separated into testa, tegmen, endosperm, and embryo, and then methanolic extracts of each sample were prepared. The traditional preparation of J. curcas seeds consists of a water extract of endosperms that is known as "milk of pinhão-branco". The content of phorbol esters (PEs) in the extracts was analyzed by High-Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD). The cytotoxic activity was evaluated in human monocytic cell line THP-1 by Resazurin Reduction Assay, and antimycobacterial activity was assessed by determining Minimal Inhibitory Concentration (MIC) values against H37Rv and BCG strains using the Resazurin Microtiter Assay (REMA). RESULTS: The content analysis revealed that the distribution of PEs within the seeds is not homogeneous. High contents were found in tegmens (4.22 ±â€¯0.25-15.52 ±â€¯0.06 mg/g) and endosperms (1.61 ±â€¯0.07-5.00 ±â€¯0.42 mg/g), while concentrations found in testas and embryos were all below 0.5 mg/g. The traditional preparation derived from the endosperm of J. curcas contained significantly less PEs than the endosperms (0.01 ±â€¯0.005 mg/g). Against THP-1 cells, all the parts of the seed showed cytotoxic activity, while the traditional preparation was considered non-cytotoxic. Nevertheless, only the tegmen and endosperm of J. curcas were considered active against M. tuberculosis and M. bovis (MIC = 200 µg/mL). CONCLUSION: The results of this study indicated that the traditional processing performed by the quilombola people from Oriximiná is effective in reducing the toxicity of J. curcas seeds. Although inactive against mycobacteria, the extensive use of the traditional preparation and its low toxicity encourage further studies to investigate other biological activities.


Asunto(s)
Jatropha , Medicina Tradicional , Ésteres del Forbol , Extractos Vegetales , Semillas/química , Antibacterianos/análisis , Antibacterianos/farmacología , Antibacterianos/toxicidad , Brasil , Supervivencia Celular/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Mycobacterium bovis/efectos de los fármacos , Mycobacterium bovis/crecimiento & desarrollo , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/crecimiento & desarrollo , Ésteres del Forbol/análisis , Ésteres del Forbol/farmacología , Ésteres del Forbol/toxicidad , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , Células THP-1
5.
Int J Antimicrob Agents ; 48(6): 753-756, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27838279

RESUMEN

Generic medicines were developed to increase population access to health treatment, to reduce costs and to allow drugs with the same outcomes to be purchased at lower prices. They are therapeutically equivalent to their brand-name counterparts and are interchangeable with them. However, the acceptance of generic medicines by physicians and general consumers is often affected by distrust related to quality and efficacy. In this study three different brands of generic amoxicillin were tested. The results showed that two of them were indistinguishable from the innovator in terms of microbiological potency; however, generic B was unable to reach the Brazilian Pharmacopoeia specifications for potency limits. In contrast, generic B was bioequivalent to the innovator amoxicillin in pharmacokinetic assessment and, surprisingly, generic A, which was approved in the microbiological potency assay, lacked pharmacokinetic equivalence compared with the innovator. Both tests, when used singly, may not be effective at detecting quality deviations in antimicrobial medicines, which indicates that pharmacokinetic tests in rats in association with microbiological potency assays are a valuable tool for post-marketing surveillance of generic antibiotics.


Asunto(s)
Amoxicilina/farmacología , Amoxicilina/farmacocinética , Antibacterianos/farmacología , Antibacterianos/farmacocinética , Medicamentos Genéricos/farmacología , Medicamentos Genéricos/farmacocinética , Vigilancia de Productos Comercializados , Amoxicilina/administración & dosificación , Animales , Antibacterianos/administración & dosificación , Medicamentos Genéricos/administración & dosificación , Humanos , Masculino , Ratas Wistar
6.
Eur J Pharmacol ; 669(1-3): 143-8, 2011 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-21864526

RESUMEN

Mast cell number and reactivity have been shown to be down-regulated under diabetic conditions. This study was undertaken in order to investigate the role of the advanced glycation end products in the reduction of mast cell number and reactivity in diabetic rats. The effect of aminoguanidine on mast cell apoptosis was also evaluated. Diabetes was induced by intravenous injection of alloxan into fasted rats and aminoguanidine was administered after 3 days of diabetes induction, once daily for 18 consecutive days. Mast cell apoptosis and levels of Bax, a pro-apoptotic member of Bcl-2 family, were evaluated by TUNEL and western blot, respectively. Diabetes led to increased levels of fructosamine and AGEs in the plasma, an effect prevented by aminoguanidine. Treatment with aminoguanidine restored mast cell numbers in the pleural cavity and in mesenteric tissue of diabetic rats. Aminoguanidine also significantly reversed the diabetes-induced reduction in histamine release, as measured by fluorescence, following activation with substance P or antigen in vitro. Increased apoptosis and levels of Bax in mast cells from diabetic rats were inhibited by aminoguanidine. In conclusion, our findings showed that aminoguanidine restored the number and reactivity of mast cells in diabetic rats, accompanied by suppression of apoptosis, evidencing that advanced glycation end product formation has a critical role in mast cell behavior of diabetic rats.


Asunto(s)
Diabetes Mellitus Experimental/inmunología , Inhibidores Enzimáticos/farmacología , Productos Finales de Glicación Avanzada/inmunología , Guanidinas/farmacología , Mastocitos/efectos de los fármacos , Animales , Antígenos/farmacología , Apoptosis/efectos de los fármacos , Glucemia/análisis , Recuento de Células , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Productos Finales de Glicación Avanzada/sangre , Insulina/sangre , Masculino , Mastocitos/inmunología , Mesenterio/inmunología , Cavidad Peritoneal/patología , Cavidad Pleural/inmunología , Ratas , Ratas Wistar , Sustancia P/farmacología , Proteína X Asociada a bcl-2/inmunología
7.
J Med Food ; 14(9): 1039-45, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21612458

RESUMEN

Different species of the family Clusiaceae, including Rheedia longifolia, are used in folk medicine to treat inflammatory diseases. This family is largely distributed in tropical and subtropical areas of Brazil, but their chemical and pharmacological properties have been the subject of a few studies. In previous studies, we found that the aqueous extract from R. longifolia leaves presented important anti-inflammatory and analgesic activity. We investigated the chemical profile of R. longifolia and characterized the pharmacological effect of different chemically identified fractions in pharmacological models of neurogenic and inflammatory nociception. The pharmacological tests showed that oral treatment with aqueous crude extract and fractions of methanol extract of R. longifolia leaf induced a significant antinociceptive effect using von Frey filaments. In addition, the most polar fractions presented antinociceptive activity in a neurogenic model of nociception (capsaicin model). The chromatographic analysis indicated the presence of bisflavonoids in the fractions obtained from the methanol extract. These results suggest that bisflavonoids found in methanol-extracted fractions are involved in the inhibition of inflammatory and neurogenic nociception. It is important that the R. longifolia aqueous extract treatment inhibited ulcer formation induced by indomethacin, suggesting an anti-ulcerogenic activity closely associated with its analgesic effect.


Asunto(s)
Analgésicos no Narcóticos/uso terapéutico , Antiinflamatorios no Esteroideos/uso terapéutico , Clusiaceae/química , Neuralgia/tratamiento farmacológico , Inflamación Neurogénica/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Analgésicos no Narcóticos/química , Animales , Antiinflamatorios no Esteroideos/química , Antiulcerosos/química , Antiulcerosos/uso terapéutico , Conducta Animal/efectos de los fármacos , Brasil , Fraccionamiento Químico , Flavonoides/análisis , Flavonoides/uso terapéutico , Masculino , Medicina Tradicional , Metanol/química , Ratones , Extractos Vegetales/química , Ratas , Ratas Wistar , Solventes/química
8.
J Med Food ; 13(2): 348-51, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20170383

RESUMEN

Bowdichia virgilioides Kunth (Family Fabaceae) is a plant that is distributed widely in the tropical and subtropical regions of the world. In the northeast region of Brazil, where B. virgilioides is called "sucupira-preta," the stem bark is used in folk medicine to treatment of inflammatory and painful diseases. This study aimed to evaluate the antinociceptive activity of the aqueous extract of the dried stem bark of B. virgilioides. The aqueous extract of B. virgilioides in doses of 50, 100, 200, and 400 mg/kg was administered orally 1 hour prior to pain induction. Only the doses of 200 and 400 mg/kg produced an inhibition by 61% and 74%, respectively, in the number of abdominal writhings induced by acetic acid. This antinociceptive effect was not reversed by pretreatment with naloxone, indicating that the effect is not associated with the activation of opioid receptors. In the formalin test, using the two highest doses, the extract had no effect in the first phase but produced an analgesic effect on the second phase with the inhibition of licking time (P < .001). In the hot plate test, no effect was seen at the dose of 400 mg/kg p.o. Our findings show that B. virgilioides contains pharmacologically active constituents that possess antinociceptive activity justifying its popular therapeutic use in treating conditions associated with the painful conditions.


Asunto(s)
Analgésicos/uso terapéutico , Fabaceae , Dolor/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Ácido Acético , Analgésicos/farmacología , Animales , Conducta Animal/efectos de los fármacos , Fabaceae/química , Formaldehído , Masculino , Ratones , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Dolor/etiología , Corteza de la Planta , Extractos Vegetales/farmacología , Tallos de la Planta
9.
J Immunol ; 180(1): 590-600, 2008 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-18097061

RESUMEN

The leukocyte integrins have critical roles in host defense and inflammatory tissue injury. We found that integrin alphaDbeta2, a novel but largely uncharacterized member of this family, is restricted to subsets of macrophages and a small population of circulating leukocytes in wild-type mice in the absence of inflammatory challenge and is expressed in regulated fashion during cytokine-induced macrophage differentiation in vitro. alphaDbeta2 is highly displayed on splenic red pulp macrophages and mediates their adhesion to local targets, identifying key functional activity. In response to challenge with Plasmodium berghei, a malarial pathogen that models systemic infection and inflammatory injury, new populations of alphaD+ macrophages evolved in the spleen and liver. Unexpectedly, targeted deletion of alphaD conferred a survival advantage in P. berghei infection over a 30-day observation period. Mechanistic studies demonstrated that the increased survival of alphaD-/- animals at these time points is not attributed to differences in magnitude of anemia or parasitemia or to alterations in splenic microanatomy, each of which is a key variable in the natural history of P. berghei infection, and indicated that an altered pattern of inflammatory cytokines may contribute to the difference in mortality. In contrast to the outcome in malarial challenge, death of alphaD-/- animals was accelerated in a model of Salmonella sepsis, demonstrating differential rather than stereotyped roles for alphaDbeta2 in systemic infection. These studies identify previously unrecognized and unique activities of alphaDbeta2, and macrophages that express it, in host defense and injury.


Asunto(s)
Antígenos CD11/metabolismo , Cadenas alfa de Integrinas/metabolismo , Macrófagos/inmunología , Malaria/inmunología , Plasmodium berghei , Salmonella , Sepsis/inmunología , Animales , Antígenos CD11/genética , Citocinas/metabolismo , Inflamación/inmunología , Cadenas alfa de Integrinas/genética , Hígado/inmunología , Activación de Macrófagos , Malaria/mortalidad , Ratones , Ratones Noqueados , Sepsis/mortalidad , Bazo/inmunología
10.
Int Immunopharmacol ; 5(13-14): 1966-74, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16275631

RESUMEN

New therapeutic approaches for the treatment of allergic diseases can be aided by the development of agents capable of regulating eosinophilic leukocytes. Here, we evaluated the anti-allergic properties of a crude extract of the Brazilian bromeliaceae Nidularium procerum, focusing on its effects on allergic eosinophilia. By studying allergic pleurisy in actively sensitized C57Bl/6 mice, we observed that pretreatment with N. procerum (2 mg/kg; i.p.) reduced pleural eosinophil influx triggered by allergen challenge. N. procerum was also able to reduce lipid body numbers found within infiltrating eosinophils, indicating that N. procerum in vivo is able to affect both migration and activation of eosinophils. Consistently, pretreatment with N. procerum blocked pleural eosinophil influx triggered by PAF or eotaxin, key mediators of the development of allergic pleural eosinophilia. The effect of N. procerum was not restricted to eosinophils, since N. procerum also inhibited pleural neutrophil and mononuclear cell influx. Of note, N. procerum failed to alter the acute allergic reaction, characterized by mast cell degranulation, oedema, and cysteinyl leukotriene release. N. procerum also had direct effects on murine eosinophils, since it inhibited both PAF- and eotaxin-induced eosinophil chemotaxis on an in vitro chemotactic assay. Therefore, N. procerum may be a promising anti-allergic therapy, inasmuch as it presents potent anti-eosinophil activity.


Asunto(s)
Antialérgicos/farmacología , Bromeliaceae , Movimiento Celular/efectos de los fármacos , Eosinófilos/efectos de los fármacos , Extractos Vegetales/farmacología , Eosinofilia Pulmonar/prevención & control , Animales , Asma/inducido químicamente , Asma/fisiopatología , Asma/prevención & control , Líquido del Lavado Bronquioalveolar/química , Líquido del Lavado Bronquioalveolar/citología , Células Cultivadas , Quimiocina CCL11 , Quimiocinas CC/metabolismo , Quimiocinas CC/farmacología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Eosinófilos/metabolismo , Femenino , Cuerpos de Inclusión/efectos de los fármacos , Cuerpos de Inclusión/metabolismo , Mediadores de Inflamación/farmacología , Interleucina-13/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ovalbúmina , Hojas de la Planta , Factor de Activación Plaquetaria/análogos & derivados , Factor de Activación Plaquetaria/farmacología , Pleuresia/inducido químicamente , Pleuresia/fisiopatología , Pleuresia/prevención & control , Eosinofilia Pulmonar/inducido químicamente , Eosinofilia Pulmonar/fisiopatología , Bazo/citología , Bazo/efectos de los fármacos , Bazo/metabolismo , Factores de Tiempo
11.
Vet Parasitol ; 134(1-2): 121-30, 2005 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-16168564

RESUMEN

Toxocara canis is a nematode of the Ascaridae family that normally parasites the small intestine of canid species. Humans are accidentally infected upon ingestion of embryonated eggs, and can manifest several clinical alterations such as fever, hepatomegaly, splenomegaly, respiratory symptoms, muscle pain and anorexia. In the present work, we investigated the kinetics of tissue distribution of L2 larva in lungs, liver, kidney, brain, skeletal muscle and myocardium. Also, we analyzed the blood and bronchoalveolar lavage fluid (BAL) for levels of IL-6, IFN-gamma, eotaxin and Regulated on Activation Normal T Cell Expressed and Secreted (RANTES) in experimental murine T. canis infection. We observed liver, lung and kidney lesions correlated to larva migration as early as the first day of infection. After the seventh post-infection day, larva could also be detected in brain, skeletal muscle and heart, as an indicator of biphasic migration pattern. Increased inflammatory activity was detected in BAL and plasma of infected animals, as was an intense eosinophil migration associated with an increase in the levels of all the cytokines studied. In conclusion, our results establish a tight correlation between tissue lesions caused by larva migration and increased plasma levels of pro-inflammatory and eosinophil chemotactic cytokines. Thus, murine T. canis infection may prove to be useful in understanding the role of cytokines in infection.


Asunto(s)
Líquido del Lavado Bronquioalveolar/inmunología , Eosinófilos/inmunología , Toxocara canis/inmunología , Toxocariasis/inmunología , Animales , Líquido del Lavado Bronquioalveolar/citología , Quimiocina CCL11 , Quimiocina CCL5/sangre , Quimiocinas CC/sangre , Modelos Animales de Enfermedad , Eosinófilos/citología , Eosinófilos/parasitología , Femenino , Corazón/parasitología , Interferón gamma/sangre , Interleucina-6/sangre , Riñón/parasitología , Hígado/parasitología , Pulmón/parasitología , Masculino , Ratones , Ratones Endogámicos BALB C , Estadísticas no Paramétricas , Toxocariasis/sangre , Toxocariasis/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...